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A general mechanism for how intracellular signaling
pathways in human pluripotent cells are coordinated
and how they maintain self-renewal remain to be
elucidated. In this report, we describe a signaling
mechanism where PI3K/Akt activity maintains self-
renewal by restraining prodifferentiation signaling
through suppression of the Raf/Mek/Erk and canon-
ical Wnt signaling pathways. When active, PI3K/Akt
establishes conditions where Activin A/Smad2,3
performs a pro-self-renewal function by activating
target genes, including Nanog. When PI3K/Akt
signaling is low, Wnt effectors are activated and
function in conjunction with Smad2,3 to promote
differentiation. The switch in Smad2,3 activity after
inactivation of PI3K/Akt requires the activation of
canonical Wnt signaling by Erk, which targets
Gsk3b. In sum, we define a signaling framework
that converges on Smad2,3 and determines its ability
to regulate the balance between alternative cell
states. This signaling paradigm has far-reaching
implications for cell fate decisions during early
embryonic development.
INTRODUCTION
Pluripotent stem cells are maintained in a stable, self-renewing
state under conditions where cell signaling pathways block
differentiation and support long-term cell division. A fundamental
understanding of how signaling pathways underpin pluripotency
has not been reached, however, and is complicated by the use of
disparate culture conditions to address this question. Despite
this, several signaling pathways are known to significantly
impact the fate of pluripotent cells (reviewed by Ohtsuka and
Dalton, 2008). These include signaling through insulin-like
growth factor (Igf)/PI3K, Activin A/Smad2,3, Raf/Mek/Erk, and
Wnt/Gsk3b signaling pathways. Although each of these path-
ways has a demonstrated role in some aspect of self-renewal,312 Cell Stem Cell 10, 312–326, March 2, 2012 ª2012 Elsevier Inc.the regulatory network underpinning pluripotency has not been
elucidated.
TGF-b/Activin A signaling is essential for the self-renewal of
human embryonic stem cells (hESCs) (Beattie et al., 2005; Xiao
et al., 2006) and functions by activating Smad2,3 via its binding
to the Alk4/Activin Receptor Type II. Upon activation and dimer-
ization, Smad2,3 maintains the pluripotent state through regula-
tion of Nanog transcription (Xu et al., 2008; Vallier et al., 2009).
Under some conditions, Activin A cooperates with Fgf2 signaling
to support pluripotency (Vallier et al., 2005), although the molec-
ular mechanism underpinning this interaction has not been
defined in detail. Paradoxically, although Activin A has a clear
role in self-renewal, it also has well-defined roles in promoting
the initial differentiation events in the epiblast and in cell fate
commitment of embryonic stem cells (McLean et al., 2007). In
developmental models such as Xenopus, Activin/Nodal sig-
naling regulates the induction of mesendoderm genes such as
XBRA (Xenopus Brachyury) and GSC (Goosecoid) (Heasman,
2006) and is therefore required for the establishment of meso-
derm and endoderm lineages (Wardle and Smith, 2006). How
Activin A promotes self-renewal under one set of conditions
and differentiation under others is not understood.
In murine ESCs (mESCs), Erk signaling antagonizes self-
renewal and so for the pluripotent state to be maintained, Mek/
Erk activity must be suppressed (Wray et al., 2010). Consider-
able confusion surrounds the role of Raf/Mek/Erk signaling in
hESCs as indicated by a number of conflicting reports, some
advocating roles in maintenance of pluripotency (Armstrong
et al., 2006; Li et al., 2007) and others suggesting it has roles
in promoting differentiation (Ding et al., 2010; Na et al., 2010).
In the embryo, however, Erk signaling has well-defined roles in
mesendoderm induction (Wardle and Smith, 2006), consistent
with it antagonizing self-renewal signaling in mESCs.
The canonical Wnt pathway is associated with early cell fate
decisions made by pluripotent cells during gastrulation. Its role
in pluripotent cells in vitro, however, has been difficult to deci-
pher again because of conflicting reports. Some studies suggest
roles for Wnt signaling and inhibition of Gsk3b in hESCs mainte-
nance (Sato et al., 2004), whereas others support in vivo data
indicative of roles in mesendoderm induction via an epithelial
to mesenchymal transition (EMT) (Sumi et al., 2008). Consistent
with the latter, key effectors of canonical Wnt signaling such as
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target genes such as XBRA (Heasman, 2006).
Although Activin A/Smad2,3, Raf/Mek/Erk, and Wnt/Gsk3b
signaling have roles in embryonic lineage commitment of plurip-
otent cells, PI3K signaling is specifically associated with mainte-
nance of pluripotency in vitro (McLean et al., 2007; Storm et al.,
2007; Watanabe et al., 2006). PI3K maintains human pluripotent
cells by suppressing the ability of specification factors, such as
Activin A, to promote differentiation (McLean et al., 2007). This
finding indicates that PI3K/Akt cooperates with Activin A to
promote the pluripotent state and suggests that Activin A has
context-dependent functions in promoting and antagonizing
self-renewal pathways.
Although several of the major intracellular signaling pathways
impacting the self-renewal of hESCs and human induced plurip-
otent stem cells (hiPSCs) have been identified, their mechanism
of action and potential ability to crosstalk as part of an integrated
network has not been addressed. In this report, we define a regu-
latory network that integrates these key pathways, thereby ex-
plaining the basic principles of self-renewal from a cell signaling
perspective. The regulatory network we define establishes the
crosstalk between PI3K/Akt, Raf/Mek/Erk, and Wnt/Gsk3b that
together impacts on the ability of Activin A/Smad2,3 to promote
either self-renewal or differentiation. This model is consistent
with developmentally established principles of early cell fate
commitment and has broad-reaching implications not just for
pluripotent stem cells in culture but also for understanding early
fate decisions in the embryo.
RESULTS
PI3K Governs the Ability of Activin A to Promote
Pluripotency or Differentiation
Inhibition of PI3K/Akt signaling in hESCs cultured with MEF-CM
is incompatible with maintenance of pluripotency and promotes
differentiation to mesoderm and endoderm (McLean et al.,
2007). The molecular mechanisms underpinning the role of
signaling pathways in maintenance of pluripotent cells including
PI3K are, however, poorly understood. To broadly understand
cell signaling networks in hESCs and how PI3K maintains plurip-
otency, we utilized a defined culture system based on StemPro
hESC SFM (HAI) (Wang et al., 2007). The rationale is that in
a defined system, factors can be added and subtracted, making
it possible to evaluate their individual roles in cell signaling and
maintenance of pluripotency. Only three recombinant factors
are required for hESC self-renewal in HAI/StemPro-defined
media: heregulin (H), Activin A (A), and Igf-1 (I). Heregulin and
Igf-1 represent potent activators of PI3K/Akt1 signaling whereas
Activin A is a regulator of pluripotency factors such as Nanog
through its activation of Smad2,3 (Xu et al., 2008; Vallier et al.,
2009). Fgf2 was not required in this media, as shown by the
fact that it is functionally redundant with heregulin and, because
it functions only at high concentrations (100 ng/ml) (Levenstein
et al., 2006), it was omitted from many of our experiments. As is
seen after inhibition of PI3K in hESCs maintained in MEF-CM,
addition of the small molecule inhibitor LY 294002 toHAI-defined
media promoted the upregulation of mesendoderm transcript
markers such as Brachyury, Eomes, Goosecoid (Gsc), and
MixL1 (Figure S1 available online). This is a similar responseCobserved when hESCs cultured in MEF-CM are treated with LY
294002 (McLean et al., 2007). Additionally, inhibitors of Akt
(Akt inhibitor XI and API-59CJ-OMe) and shRNA knockdown of
Akt1, Akt2, and Akt3 also promoted the upregulation of mesen-
doderm transcript markers (Figure S1).
Omission of Igf-1 and heregulin (HI) from defined media had
a similar effect to that of LY 294002 treatment. Most notably,
mesendoderm marker transcripts Eomes and MixL1 increased
within 2 days and pluripotency markers Nanog and Oct4
declined by day 4 (Figure 1A). Immunostaining revealed an
increase in Brachyury protein at day 2 and a decrease in Nanog
protein within 4 days (Figure 1B). Loss of Akt1 activity, as judged
by its phosphosphorylation on residue threonine 308 and serine
473 (pAktT308 and pAktS473), and ribosomal S6 phosphorylation
decreased within 24 hr (Figure 1C). These results indicate that
Igf-1 and heregulin are activators of Akt in hESCs. In addition
to the data shown with BG02 hESCs, these general findings
were replicated in WA01, WA07, and WA09 hESC lines (Fig-
ure S1). To formally show that Akt is a major effector of PI3K
signaling in hESCs, a myristoylated, constitutively active version
of Akt (myr.AKT) was expressed in cells cultured in the absence
of Igf-1 and heregulin. This blocked the upregulation of Eomes,
Gsc, andMixL1 transcripts after loss of PI3K activity (Figure 1D),
showing that Akt1 is a major effector of the PI3K-dependent
differentiation blockade in hESCs. Furthermore, a stable hESC
line expressing myr.AKT was able to maintain pluripotency
markers in the absence of heregulin and Igf-1 for more than
five passages (Figure S1). These data indicate that Akt is the
major effector of heregulin and Igf-1 signaling and is required
to maintain pluripotency.
Another major self-renewal pathway identified in hESCs
depends on the signaling of Activin A through Smad2,3 (Beattie
et al., 2005; Xiao et al., 2006). On the surface this seems counter-
intuitive because Activin A and Smad2,3 are known inducers of
differentiation and yet in hESCs they also perform a role in
hESC maintenance. To evaluate the potential dual role of Activin
A in self-renewal and differentiation, we used SB 431542 (SB), an
antagonist of TGF-b receptors (Alk4,5,7). Addition of SB blocked
the upregulation of differentiation markers in response to with-
drawal of PI3K/Akt activators Igf-1 and heregulin (Figures 1E
and 1F), indicating that Activin A/Smad2,3 signaling is required
for mesendoderm induction. Nanog transcript and protein levels
also declined after treatment with SB under self-renewal (+HAI)
and differentiation (HI) conditions (Figure 1F and data not
shown). This is consistent with established roles for Activin
A/Smad2,3 signaling in regulation of Nanog transcription (Xu
et al., 2008; Vallier et al., 2009). Together, these results indicate
that Activin A/Smad2,3 promotes self-renewal when PI3K/Akt
activity is elevated but promotes differentiation when PI3K/Akt
activity is low (Sato et al., 2004; Sumi et al., 2008; Ying et al.,
2008).
To investigate the relationship between PI3K/Akt and Activin A
further, we focused on transcriptional regulation of MIXL1,
a mesendoderm gene that is rapidly activated after loss of
PI3K/Akt signaling. By using a MixL1-luciferase reporter, we
found that loss of PI3K signaling (HI) increased luciferase
activity and that this was blocked by addition of SB (Figure 1G).
Loss of PI3K/Akt signaling was a requirement for the activation of
the reporter even in increasing concentrations of Activin Aell Stem Cell 10, 312–326, March 2, 2012 ª2012 Elsevier Inc. 313
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Figure 1. Activin A Promotes Self-Renewal or Differentiation Depending on the Status of PI3K/AKT Signaling
(A) Transcript markers of BG02 hESCs in HI.
(B) Immunostaining of BG02 hESCs in HI. Scale bar represents 50 mm.
(C) Immunoblot analysis of BG02 hESC lysates in HAI or HI for 24 hr.
(D) Transcript markers after transfection of WA09 hESCs with a myr.AKT-IRES-GFP expression vector in +HAI media. 24 hr after transfection, GFP+ and GFP
cells were isolated by FACS, plated, and then grown in HI for 3 days.
(E) Transcript markers in HI in WA09 hESCs after 4 days ±SB 431542 (20 mM).
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genes associated with mesendoderm induction therefore
requires conditions where PI3K activity is low.
Toward understanding how PI3K controls cell fate through
Activin A signaling, we asked whether Smad2,3 activity varies
in response to changes in PI3K/Akt activity. In this scenario,
a threshold of Smad2,3 activity would control a switch that deter-
mines the decision to self-renew or differentiate. This was
addressed by assessing Smad2,3 phosphorylation under
conditions where PI3K/Akt is active or inactive (±HI). Under
self-renewing conditions (+HAI), a baseline of activated
Smad2,3 was detected, consistent with its requirement for
self-renewal (Figure 1H). In the absence of PI3K activation,
Akt1 activity was lost and surprisingly Smad2,3 activity was
significantly elevated. Smad2,3 activity and Nanog levels under
these conditions were dependent on Activin A in a dose-depen-
dent manner. This trend was reversed, however, when Akt1
signaling was restored by addition of HI or HIF (Figure 1H).
Increased activity of Smad2,3 in the absence of PI3K signaling
(HI) was confirmed with an Activin response element (ARE)-
luciferase reporter construct (Figure S1; Weisberg et al., 1998).
ARE activation is dependent on Smad2,3 but independent of
Wnt, as shown by insensitivity to Dkk1. The status of PI3K/Akt
signaling therefore regulates the threshold levels of Activin A/
Smad2,3 signaling to activate different subsets of target genes
to impact cell fate decisions. A model to explain these findings
is shown in Figure 1I.
The PI3K Self-Renewal Signal Suppresses Erk and
Maintains Gsk3b Activity
Upon further examination of signaling pathways in response to
PI3K inhibition, we observed that phosphorylation of Erk1,2
(pErk1,2T202,Y204) and Gsk3b (pGsk3bS9) (Figure 2A) increased
within 12 hr of LY 294002 treatment. These changes represent
activation of the MAPK/Erk pathway and inactivation of Gsk3b
activity, respectively. These data were also confirmed with
MEF-CM (Figure S2), indicating that the cell signaling networks
downstream of PI3K are preserved in defined media and
MEF-CM. Consistent with previous data (Figure 1), levels of acti-
vatedSmad2,3 increasedwith loss of PI3K activity (Figure 2A). All
of thesesignalingchangespreceded lossofNanogandare there-
fore early responses to self-renewal pathways being disrupted.
To understand more precisely the signaling requirements
controlling Erk1,2 and Gsk3b activity in hESCs, cells were
starved of all factors for 24 hr (HAI), then stimulated with the
indicated factors for a further 3 hr. In the absence of all three
factors (low Akt1 activity), Erk1,2 was activated and Gsk3b inac-
tivated (Figure 2B), consistent with responses seen in Figure 2A
when PI3K is directly inhibited with LY 294002. Igf-1 and heregu-
lin blocked these changes whereas Activin A did not, consistent
with PI3K activation being required for these events. Heregulin
and Igf-1 displayed a synergistic effect in their ability to activate(F) Immunoblot analysis of BG02 hESC lysates from cells grown in HI for 2 and
(G) MixL1 promoter-luciferase assays. 24 hr after transfection, WA09 hESCs we
(H) Immunoblot analysis of BG02 hESC in +HAI media and starved of factors fo
A, Activin A (10 or 100 ng/ml); I, Igf-1 (200 ng/ml); F10, Fgf2 (10 ng/ml).
(I) Model summarizing results.
Data are mean ± SEM; *p < 0.05, **p < 0.01. See also Figure S1.
CAkt (Figure S2), explaining the requirement for both factors in
StemPro/HAI media. At low levels, Fgf2 (F10; 10 ng/ml) had
only a minimal effect on Erk1,2 and Gsk3b, but when increased
to 100 ng/ml (F100) it reproduced the effects seen with addition
of Igf-1 and heregulin (Figure 2C), indicating that it operates
through a similar signaling cascade to these factors. This is
consistent with Fgf2 being able to substitute for heregulin in
long-term self-renewal assays when present at high levels
(data not shown; see Discussion).
To directly address the role of Akt1 in regulation of Erk1,2 and
Gsk3b, WA09 hESCs were transfected with a myr.AKT-IRES-
GFP expression construct in complete defined media (+HAI).
After sorting, GFP+/ cells were grown inHImedia and assayed
by immunoblot analysis to evaluate the status of Erk1,2 and
Gsk3b (Figure 2D). Cells expressing myr.AKT1 had low Erk1,2
activity and elevated Gsk3b activity in contrast to GFP cells,
consistent with results shown in Figure 2A. Maintaining Akt1
activity in pluripotent cells is therefore critical for suppression
of Erk1,2 activity and for the maintenance of Gsk3b activity.
Previous studies have demonstrated that Akt can directly bind
and phosphorylate cRaf, leading to the inhibition of Raf/Mek/Erk
signaling (Rommel et al., 1999). Immunoprecipitation assays
performed in hESCs confirmed an Akt1-cRaf interaction, sug-
gesting that this is the mechanism by which Akt blocks Erk
signaling (Figure 2E).
To further examine the ability of Akt to repress Erk signaling,
we utilized fluorescence resonance energy transfer (FRET) and
the EKAR/Erk FRET reporter (Harvey et al., 2008). After transfec-
tion of hESCs with EKAR, PI3K inhibition via LY 294002 led to
a strong FRET response after approximately 45 min (Figure 2F).
These data demonstrate that PI3K/Akt inhibits Erk activity in vivo.
In total, these data indicate that the PI3K pathway crosstalks
with Erk1,2 and Gsk3b signaling pathways to maintain hESCs
(Figure 2G).
Raf/Mek/Erk Antagonizes Self-Renewal by Inhibition
of Gsk3b
Although Erk signaling increases under conditions of low PI3K/
Akt activity, the significance of this in terms of self-renewal is
unclear. Roles for elevated Erk activity were therefore evaluated
by overexpression of a dominant-negative Erk1 (dnErk1) or by
addition of the Mek inhibitor UO126. In both cases the upregula-
tion of early differentiation markers such as Brachyury, Eomes,
Gsc, and MixL1 was blocked after loss of PI3K signaling (HI)
and Erk suppression (Figures 3A–3C). UO126 also blocked the
downregulation of Nanog under these conditions (Figure 3C).
Not only did Mek inhibition block differentiation in low PI3K/Akt
activity, it also suppressed the inactivation of Gsk3b (Figure 3D),
supporting the idea that Mek/Erk signaling inhibits Gsk3b
activity.
The role of Raf, an upstream regulator of Mek and Erk, was
then evaluated by ectopic expression of a constitutively active4 days, ±SB 431542.
re cultured for 2 days in +HAI, HI, or HI +SB 431542 and assayed.
r 18 hr. Factors were readded for 3 hr as indicated. H, heregulin (10 ng/ml);
ell Stem Cell 10, 312–326, March 2, 2012 ª2012 Elsevier Inc. 315
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Figure 2. Activin A Regulates Erk and Gsk3b in the Absence of PI3K/AKT Activity
(A) Immunoblot of BG02 hESCs ±LY 294002 (50 mM) for 12 hr.
(B) WA09 hESCs were starved of factors for 24 hr (HAI) then stimulated with factors as indicated for 3 hr; +H, heregulin (10 ng/ml); +A, Activin A (10 ng/ml); +I,
Igf-1 (200 ng/ml); +F10, Fgf2 (10 ng/ml).
(C) WA09 hESCs (+HAI) were treated and analyzed as in (B) with indicated factors for 3 hr.
(D) WA09 hESCs (+HAI) were transfected with myr.AKT-IRES-GFP expression vector. GFP+ and GFP cells were isolated by FACS, plated in +HAI media for
24 hr, then plated in HI media for 2 days.
(E) Immunoprecipitation of WA09 hESCs (+HAI) with Akt1 and Raf1, followed by immunoblotting.
(F) ERK activation measured as the ratio of YFP/CFP fluorescence in WA09 hESCs (+HAI) transfected with EKAR. The ratio average ± SEM for untreated cells
(10; black line) and LY 294002-treated cells (7; red line).
(G) Model summarizing data.
Data are mean ± SEM; *p < 0.05, **p < 0.01. See also Figure S2.
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Signaling Network Crosstalk in Pluripotent CellscRaf mutant (McCubrey et al., 1998). Cells expressing cRaf
(GFP+) upregulated differentiation markers even under condi-
tions where PI3K/Akt remained active (Figure 3E). Cells not ex-
pressing active cRaf (GFP) maintained low levels of Eomes,
Gsc, and MixL1 mRNAs. Immunoblot analysis shows that cRaf
activated Erk1,2 and inactivated Gsk3b (Figure 3F). Expression
of tamoxifen-regulated, constitutively activeMek (MEK-ER) (Bla-
lock et al., 2000) had similar effects on Erk1,2 and Gsk3b activity,
and mesendoderm differentiation markers as was seen for acti-
vated cRaf (Figures 3G and 3H). Previous reports have found that
Erk directly binds Gsk3b, which promotes its inactivation
through a priming phosphorylation (Ding et al., 2005). Immuno-
precipitation (IP) assays confirmed that this interaction also
occurs in hESCs (Figure 3I), indicating that Erk regulates
Gsk3b directly. Next, the requirement for Mek activity in Gsk3b
inactivation was evaluated with IP-kinase assays. These assays
show that under conditions of low PI3K activity (HI), UO126
blocks the inactivation of Gsk3b kinase (Figure 3J). Because
b-catenin is a direct effector of Wnt/Gsk3b signaling, we asked
whether it was activated after loss of PI3K activity, with the
Top-Flash/Fop-flash luciferase reporter and LY 294002. Top-
Flash activity increased after treatment with LY 294002 but
was blocked by addition of the Mek inhibitor UO126. These
results show that the activation of Erk1,2 inactivates Gskb, in
response to reduced PI3K signaling. After this, Wnt effectors
such as b-catenin are activated (see Figure 3L).
GSK3b Is Required for the Self-Renewal of Human
Pluripotent Stem Cells
By several criteria we have shown that Gsk3b inactivation, after
the loss of PI3K/Akt signaling and activation of Erk1,2, coincides
with loss of self-renewal. This suggests that Gsk3b is required to
maintain pluripotent cells in a self-renewing state. To investigate
this, we treated hESCs with a Gsk3b small molecule inhibitor
(BIO) and show that it promotes the downregulation of Nanog
and upregulation of Brachyury, Eomes, and MixL1 transcripts
over a period of 1–2 days (Figure 4A). This coincided with loss
of E-cadherin and Nanog protein in addition to the nuclear accu-
mulation of b-catenin and Snail (Figure 4B). Together, these
events are characteristic of an EMT and indicate that Gsk3b
inhibition drives pluripotent cells into an early differentiated state
by activation of canonical Wnt signaling effectors. These findings
were reproduced with hESCs grown in MEF-CM, mTeSR1, and
with other Gsk3b inhibitors (Figures S3 and S4).
To demonstrate that Gsk3b is required for hESC self-renewal
by a genetic approach, we assayed the effects of a Cre-
activated, dominant-negative (dn) version of Gsk3b (Figure S4C;
Hagen et al., 2002). After Cre expression, elevated levels of
Brachyury and Snail were seen in the nucleus whereas levels
of Nanog, E-cadherin, and b-catenin declined (Figure S4D).
Interferingwith Gsk3b activity therefore activates events reminis-
cent of an EMT and events associated with mesendoderm
induction. To establish whether Gsk3b lies downstream of
Mek/Erk, we asked whether UO126 could block the upregulation
of differentiation markers after BIO treatment. By itself, Gsk3b
inhibition with BIO upregulates differentiation markers but is
unaffected by Mek inhibition (Figure 4C). Gsk3b inactivation is
therefore sufficient to promote differentiation, indicating that
a major function of Erk is to regulate Gsk3b. These data areCconsistent with known roles for Gsk3b as an antagonist of
canonical Wnt signaling and provide a model for the basic
signaling requirements that promote self-renewal.
In contrast to our observations, inhibition of Gsk3 has been re-
ported to promote self-renewal of hESCs in short-term assays
(Sato et al., 2004). Other recent studies, however, show that
Gsk3 inhibitors have dose-dependent effects where at low
concentrations they promote self-renewal but at higher concen-
trations they promote differentiation (Tsutsui et al., 2011; Li et al.,
2012). One explanation for these phenomena is that different
pools of Gsk3 in the cell have different activation thresholds for
signaling. For example, Gsk3 is a target of PI3K/Akt signaling
in addition to being a regulator of the canonical Wnt pathway—
these compartments are physically separate and regulated by
distinct mechanisms (Voskas et al., 2010). This establishes a
potential scenario where different doses of Gsk3 inhibitors may
result in differing biological outcomes. To test this hypothesis,
hESCs were treated with increasing concentrations of the
Gsk3 inhibitor BIO. Interestingly, we found that BIO treatment
at low concentrations (<1 mM) led to decreased phosphorylation
on c-myc on threonine 58 (Figure 4D). Decreased T58 phosphor-
ylation, leading to enhanced c-myc stability, is known to be a
positive determinant of self-renewal in ESCs (Cartwright et al.,
2005). Gsk3 inhibition under these conditions, however, had
a negligible effect on b-catenin Top-Flash reporter activity, indi-
cating that canonical Wnt signaling was not affected under these
conditions (Figure 4E). Importantly, loss of pluripotency markers
such as Nanog and Tra-1-80 occurred only at higher concentra-
tions of BIO (>2.0 mM), coinciding with activation of the Top-
Flash reporter (Figures 4F and 4G). These data show that lower
concentrations of Gsk3 inhibitor promote self-renewal through
mechanisms such as Myc stabilization, whereas higher concen-
trations of Gsk3 inhibitor promote differentiation through activa-
tion of Wnt/b-catenin. In summary, these results indicate the
existence of a crosstalk mechanism between PI3K/Akt, Raf/
Mek/Erk, and Gsk3b signaling that controls self-renewal in
human pluripotent cells.
Wnt Signaling Antagonizes Self-Renewal in Human
Pluripotent Cells
Although elevated Wnt/b-catenin signaling promotes differentia-
tion, basal b-catenin activity under self-renewing conditions may
be important for sustaining pluripotency (Sumi et al., 2008).
Although exogenous Wnt ligands are not included in our culture
media, the low level of basal Wnt activity detected in our assays
is most probably due to an autocrine production by hESCs
themselves (Figure S5). To investigate possible roles for basal
Wnt/b-catenin activity in self-renewal, we inhibited Wnt activity
with Dkk1. Under these conditions, hESCs could be maintained
for >1 month without any adverse effects on cellular morphology
or loss of pluripotency markers (Figure 5A and data not shown).
Inhibition of Wnt signaling by Dkk1 was confirmed with the
Top-Flash/Fop-Flash reporter assay (Figure 5B). Because
a background level of differentiation is typically seen in most
hESC cultures, we asked whether this could be suppressed by
inhibition of Wnt signaling by Dkk1. Addition of Dkk1 almost
completely suppressed the small percentage of Brachyury-
positive cells routinely seen in hESC cultures while retaining
Nanog expression (Figure 5A). As a more sensitive assay withell Stem Cell 10, 312–326, March 2, 2012 ª2012 Elsevier Inc. 317
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Figure 3. Raf/Mek/Erk Signaling Promotes the Differentiation of hESCs and Inhibits Gsk3b
(A) Transcript markers in HI for 3 days, with or without transfection of dnErk1 from WA09 hESCs.
(B) Transcript levels from WA09 hESCs (HI) after 4 days ±U0126 (20 mM).
(C) Immunoblot analysis of BG02 hESC lysates (HI) for 2 and 4 days, ±U0126.
(D) Immunoblot analysis of WA09 hESC lysates in HI, ±U0126.
(E) Transcript markers after transfection and FACS of WA09 hESCs with a constitutively active cRAF-IRES-GFP vector after culture (+HAI) for 3 days.
(F) Immunoblot analysis after transfection and FACS of WA09 hESCs with a constitutively active cRAF-IRES-GFP vector. Cell lysates prepared after a further 3 hr
culture in HI media.
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Eomes, Gsc, Sox17, and Gata6 transcripts are suppressed in
cultures maintained in the presence of Dkk1, whereas Nanog
transcripts increased slightly (Figure 5C). By flow cytometry,
the percentage of SSEA3+ cells increased in the presence of
Dkk1 (Figure 5D). Taken together, these data indicate that
suppression of Wnt signaling stabilizes pluripotent cells.
Our data show that Erk-dependent inactivation of Gsk3b
signaling has a major role in destabilizing the pluripotent state.
Next, we asked whether the canonical Wnt pathway was a focal
point for this regulation by asking whether Wnt ligands generate
a signal that destabilizes pluripotent cells under conditions of low
PI3K activity (HI) and elevated Raf/Mek/Erk activity. This was
first addressed by culturing hESCs in the absence of HI and in
the presence or absence of Dkk1. Inhibition of Wnt signaling
by Dkk1 blocked the activation of early differentiation markers
in this assay (Figure 5E), confirming that destabilization of hESCs
after loss of PI3K/Akt is dependent on Wnt signaling. Dkk1 did
not have any nonspecific effects on the phosphorylation status
of Erk, Gsk3b, Smad2, or c-myc, consistent with its function of
specifically blocking Wnt signaling (Figure S5). Dkk1 also
blocked the upregulation of differentiation markers after the
expression of active cRaf (Figure 5F). Both of these findings
are consistent with our model that a crosstalk mechanism
between PI3K, Erk, and Gsk3b converges on Wnt signaling
(Figure 5G).
Smad and Wnt Signaling Pathways Coordinately
Converge on Target Genes
A key finding of our work so far shows that Activin A/Smad2,3
switches from having a pro-self-renewal function to a prodiffer-
entiation function in the absence of PI3K/Akt signaling. A mech-
anism underpinning these observations is suggested from
our findings that Activin A/Smad2,3 promotes differentiation
through activation of Erk signaling, through the subsequent
repression of Gsk3b and after activation of Wnt effectors such
as b-catenin and Snail. Because Activin A/Nodal signaling
induces mesoderm and definitive endoderm development in
the vertebrate embryo, we asked whether Smad2,3 signaling
synergizes with the Wnt pathway to promote the activation of
mesendoderm genes in hESCs. This would therefore test
whether the combinatorial action of Activin A with Wnt effectors
switches the activity of Smad2,3 to a prodifferentiation function.
To test this hypothesis, mesendoderm differentiation was
induced by the Gsk3 inhibitor/Wnt pathway agonist BIO, in the
presence or absence of SB 431542 (SB) (Figure 6A). As ex-
pected, Gsk3 inhibition upregulated the mesendoderm markers
Eomes, Gsc, and MixL1 but this was blocked by inhibiting
Activin A signaling with SB. Nanog was downregulated in
BIO, or in BIO and SB, consistent with our findings that Gsk3
inhibition promotes the loss of pluripotency and the role of Acti-(G) Immunoblot analysis of WA09 hESC lysates (+HAI) having a constitutively act
for 24 hr.
(H) Transcript markers of WA09 hESCs containing a constitutively active MEK-E
(I) Immunoprecipitation of WA09 hESCs (+HAI) with Erk1,2 and Gsk3b, followed
(J) Immunoprecipitation (IP)-kinase assays for Gsk3b of WA09 hESCs cultured in
(K) Luciferase assay of WA09 hESCs treated with LY 294002 ± U0126 for 2 days
(L) Model summarizing the data.
Data are mean ± SEM; *p < 0.05, **p < 0.01.
Cvin A/Smad2,3 in regulating Nanog (Figures 1E and 1F; Xu et al.,
2008; Vallier et al., 2009). Additionally, we have recently
described the use of BIO and SB as a method to promote neural
crest differentiation from hESCs (Menendez et al., 2011). This
indicates that Wnt effectors (i.e., b-catenin) act in conjunction
with Smad2,3 to activate mesendoderm genes. SB also blocked
the BIO-dependent activation of a MixL1-luciferase reporter,
indicating that this regulation occurs at the level of transcription
(Figure 6B). To evaluate the binding of Smad2,3 and b-catenin
during mesendoderm induction of hESCs, chromatin immuno-
precipitation assays were performed (Figure 6C). Low levels of
Smad2,3 were found on the MixL1 promoter in hESCs and after
treatment with BIO. b-catenin binding, however, increased
significantly after BIO treatment. Interestingly, in the presence
of SB, b-catenin binding to the MixL1 promoter was lost, sug-
gesting that the presence of Smad2,3 on the promoter is
a prerequisite for binding by b-catenin. No significant changes
of Smad2,3 enrichment on the Nanog promoter were observed
in the presence of BIO (data not shown). These data show that
upon Gsk3 inhibition, b-catenin binding at the MixL1 promoter
increases, indicating that it synergizes with Smad2,3 to promote
transcription.
To further test the hypothesis that Smad and Wnt effectors
cooperate to regulate mesendoderm markers, we transiently
transfected hESCs (+HAI complete definedmedia) with constitu-
tively active Smad3 (caSmad3) (Funaba and Mathews, 2000),
along with the MixL1-luciferase reporter (Figure 6D). Transfec-
tion of caSmad3 increased MixL1 promoter activity 8-fold,
supporting the idea that a threshold of Smad2,3 signaling
in hESCs is limiting for activation of mesendoderm genes (Fig-
ure 6C). Because a low level of Dkk1-sensitive Wnt signaling
can be detected in hESCs (see Figure 6), we included Dkk1 to
establish whether Wnt is also required for MixL1 transcription
under these conditions. This was confirmed by the observation
that in the presence of caSmad3, Dkk1 reduces MixL1 promoter
activity to that below steady-state levels in control hESCs.
Activation ofMixL1 therefore requires Smad2,3 activity in combi-
nation with effectors of the canonicalWnt pathway. Furthermore,
the transfection of a caSmad3 upregulated mesendoderm tran-
scripts, but not in the presence of Dkk1 (Figure 6E), further
demonstrating that Smad2,3 and b-catenin cooperate to acti-
vate mesendoderm genes. These data support the model that
once PI3K/Akt activity declines, Activin A switches to a prodiffer-
entiation mode of regulation by collaborating with the Wnt
pathway. A model to describe the observations made
throughout this report is shown in Figure 7.
DISCUSSION
PI3K/Akt, Raf/Mek/Erk, Activin/Smad, and Wnt/b-catenin sig-
naling pathways have all been implicated in regulating humanive MEK-ER transgene or empty vector, ±100 nM 4-hydroxy-tamoxifen (4OHT)
R transgene or vector control, ±100 nM of 4OHT for 3 days (+HAI).
by immunoblotting.
media with +HAI, HI, HI +U0126, or HI +Dkk1 (150 ng/ml).
after transfection of Top-Flash or Fop-Flash reporters.
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Figure 4. Loss of Gsk3b Activity Promotes Mesendoderm Differentiation of hESCs
(A) Transcript markers in BG02 hESCs in +HAI media, ±BIO (2 mM).
(B) Immunofluorescence of BG02 hESCs ±BIO.
(C) Transcript markers of WA09 hESCs with BIO ±U0126 for 3 days.
(D) Immunoblot analysis of WA09 hESCs treated with increasing doses of BIO after 24 hr.
(E) Luciferase assays in WA09 hESCs treated with increasing doses of BIO, 48 hr after transfection.
(F) Transcript markers of WA09 hESCs treated with increasing doses of BIO for 72 hr.
(G) Immunofluorescence of WA09 hESCs treated with increasing doses of BIO for 72 hr.
Scale bars represent 100 mm. Data are mean ± SEM; *p < 0.05, **p < 0.01. See also Figures S3 and S4.
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pathways cooperate to maintain the balance between self-
renewal and differentiation has been unclear. With a simple,
defined culture system that forms the basis of StemPro hESC
SFM (Wang et al., 2007), we describe a crosstalk mechanism
where PI3K/Akt suppresses the activation of prodifferentiation
pathways centering around Raf/Mek/Erk and canonical Wnt
signaling. The signaling crosstalk described here is widely
applicable to all hESC media types, including MEF-CM,
StemPro, and mTesr1. Only two extrinsically activated signaling
pathways are required to maintain pluripotency: (1) activation of
Smad2,3 and its downstream targets, such as Nanog, by Activin
A/Nodal (Xu et al., 2008; Vallier et al., 2009); and (2) the activation
of PI3K/Akt signaling by factors such as Igf-1, heregulin, and
Fgf2. These two signaling requirements can be identified in all
hESCmedia formulations described to date. For example, serum
contains high levels of Igfs and knockout serum replacement
(KSR) contains high levels of insulin. Sources of Activin A include
MEF feeder layers, MEF-CM in addition to its inclusion in defined
media formulations (Ludwig et al., 2006; Wang et al., 2007; Yao
et al., 2006). hESCs also produce Nodal, a TGF-b member that
can signal through the Activin A/Alk4 receptor to activate
Smad2,3. Wnt ligands produced by human pluripotent cells
appear to be sufficient for activation of downstream targets
such as b-catenin and Snail in the absence of PI3K/Akt signaling,
although addition of exogenous Wnt3a has been reported to
enhance rates and efficiencies of mesendoderm differentiation
(D’Amour et al., 2005).
Together, our studies show that PI3K/Akt regulates the ability
of Activin A/Smad2,3 to control the balance between self-
renewal and differentiation (see Figure 7). Under self-renewing
conditions, PI3K/Akt suppresses Erk andWnt signaling, allowing
Smad2,3 to activate a specific subset of target genes required
for self-renewal. In the absence of PI3K/Akt signaling, however,
Erk andWnt pathways are activated and effectors such as b-cat-
enin and Snail can permit Smad2,3 to activate genes that direct
early differentiation and EMT. Besides the activation of Wnt
signaling, loss of PI3K increases the threshold of phosphorylated
Smad2,3, enabling it to target a subset of genes that are not
active under self-renewing conditions. Precisely how Akt regu-
lates Smad2,3 thresholds is unclear, but may involve the direct
interaction and sequestration of Smad3 out of the nucleus
(Conery et al., 2004; Remy et al., 2004). How pluripotency genes
become inactivated under these conditions is also unclear
but could involve a negative feedback loop of some kind
once early differentiation genes are activated. Interestingly,
pluripotency factors such as Nanog and Oct4 have been
recently implicated in the initiation of differentiation (Teo et al.,
2011; Yu et al., 2011; Thomson et al., 2011), which may account
for their continued expression during the initial stages of
differentiation.
Despite its well-established role in antagonizing pluripotency
in mESCs, the role of Erk in human pluripotent cells has been
more open to question (Armstrong et al., 2006; Li et al., 2007;
Ding et al., 2010; Na et al., 2010). Although we find that elevated
Erk activity promotes mesendoderm differentiation, we cannot
rule out the possibility that low levels of Erk signaling are impor-
tant for hESC maintenance. In this scenario, Erk signaling would
bemaintained below a threshold level to permit self-renewal, butConce this level is surpassed, mesendoderm differentiation would
initiate. Recent work has suggested that Erk signaling may
promote the expression of Nanog during the initial stages of
mesendoderm differentiation (Yu et al., 2011). Our work is
consistent with this finding.
For some time the exact roles of Fgf2 and Wnt signaling in
maintenance of human pluripotent cells have remained unclear.
We believe a confounding problem in dissecting the roles of
many signaling pathways has been the complexity and inconsis-
tencies of media formulations such as MEF-CM. In our assays,
Fgf2 has no consistent effect on Akt, Erk, or Gsk3b at low
concentrations (F10). However, at high concentrations (F100) it
regulates Akt, Erk, and Gsk3b in a manner comparable to that
of Igf-1 and heregulin. Several reports have described the
need for high levels of Fgf2 in feeder-free media formulations,
consistent with our findings (Levenstein et al., 2006; Yao et al.,
2006). In our studies we routinely used heregulin in place of
Fgf2 because it functions at low concentrations and therefore
provided cost benefits, but cells can be maintained long-term
(>10 passages) in AIF100 media (data not shown). Signaling in
AIF100 and HAI media was indistinguishable. The reason for
requiring two sources of PI3K activators for long-term self-
renewal is not understood. One possibility is that sustained
PI3K signaling requires multiple activators of PI3K. This is sug-
gested by studies indicating that different receptor tyrosine
kinases activate PI3K with different kinetics (see Zhang et al.,
2002). Sustaining PI3K signaling over time may therefore require
two activators with different activation kinetics.
We have addressed the role of Wnt/Gsk3b signaling in hESCs
in numerous ways with (1) multiple chemical inhibitors (BIO,
GSKi-XV, CHIR99021), (2) the Wnt antagonist Dkk1, and (3)
a genetic approach with a DN-GSK3. Additionally, these anal-
yses were performed with multiple cell lines and multiple media
conditions (HAI, StemPro, MEF-CM, mTesr1). Collectively we
find that Wnt signaling is antagonistic to self-renewal and
promotes differentiation of hESCs, but only if Erk and Activin/
Smad signaling pathways are active.
Our experiments show that different concentrations of Gsk3
inhibitors have different biological effects and reconcile conflict-
ing reports in the literature (Sato et al., 2004; James et al., 2005;
Xiao et al., 2006; Villa-Diaz et al., 2009; Ding et al., 2010; Dravid
et al., 2005; Sumi et al., 2008; Hay et al., 2008; Bone et al., 2011).
These findings are in agreement with a recent report showing
that Gsk3 inhibitors have dose-dependent effects; at low
concentrations they stabilize pluripotent cells and at high
concentrations they promote differentiation (Tsutsui et al.,
2011; Li et al., 2012). At the biochemical level, these findings
can be explained by the presence of different Gsk3 complexes
that perform separate biochemical functions (Voskas et al.,
2010). In this scheme, the biological effects of separate Gsk3
complexes would be subject to different signaling thresholds.
In pluripotent cells, Myc is stabilized at low concentrations of
inhibitor, whereas b-catenin target gene activation requires
higher concentrations. Here, Gsk3 complexes controlling Myc
are part of the canonical PI3K/Akt pathway and serve to antag-
onize self-renewal pathways (Singh andDalton, 2009; Cartwright
et al., 2005; Smith et al., 2010; Takahashi and Yamanaka,
2006). Increased Myc stability therefore provides an explanation
for how hESC self-renewal is promoted at low inhibitorell Stem Cell 10, 312–326, March 2, 2012 ª2012 Elsevier Inc. 321
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Figure 5. Inhibition of Wnt Signaling by Dkk1 Stabilizes Human Pluripotent Cells
(A) Immunofluorescence analysis of WA09 hESCs in +HAI, ±Dkk1 (150 ng/ml) for six passages. Scale bars represent 50 mm.
(B) Luciferase assay of WA09 hESCs in +HAI, ±Dkk1 for six passages 2 days after transfection. Values expressed as ratio of Top-Flash to Fop-Flash signals.
(C) Transcript levels in WA09 hESCs (+HAI) after treatment with Dkk1 for 4 days.
(D) Flow cytometry analysis of WA09 hESCs cultured ±Dkk1 for six passages.
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Figure 6. Wnt/b-catenin and Activin/Smad Signaling Cooperate to Regulate Mesendoderm Gene Expression
(A) Transcript markers of WA09 hESCs grown in +HAI, ±BIO (2 mM), ±SB 431542 (20 mM).
(B) MixL1-luciferase reporter assays in WA09 hESCs cultured in +HAI medium after addition of BIO ±SB 431542 after 3 days.
(C) Chromatin immunoprecipitation assay of WA09 hESCs (+HAI) after the addition of BIO or BIO + SB 431542 for 12 hr with Smad2,3 and b-catenin on the MixL1
promoter.
(D) MixL1-luciferase assays in +HAI media cotransfected with vector alone or caSmad3, ±Dkk1 (150 ng/ml) for 3 days.
(E) Transcript markers of WA09 hESCs after transfection and FACS for a caSmad3-IRES-GFP vector ±Dkk1.
Data are mean ± SEM; *p < 0.05, **p < 0.01.
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b-catenin resulting in loss of pluripotencymarkers and increased
levels of mesendoderm markers, consistent with the well-estab-
lished role of Wnt in differentiation and development. The pool of
Gsk3 required for this is part of the canonical Wnt pathway and
quite separate from that which regulates substrates such as
Myc. Together, these findings explain many of the discrepancies
in the literature as to the function of Wnt/b-catenin signaling and
Gsk3 inhibitors in hESCs.
Recent studies suggest that b-catenin is not required to main-
tain the pluripotency of mESCs (Lyashenko et al., 2011; Wray
et al., 2011). However, low levels of b-catenin may promote plu-(E) Transcript markers in HI, ±Dkk1.
(F) Transcript markers after transfection and FACS of a constitutively active cRA
(G) Model summarizing the data from Figures 4 and 5.
Data are mean ± SEM; *p < 0.05, **p < 0.01. See also Figure S5.
Cripotency of ‘‘naive’’ ESCs by blocking Tcf3-based repression (Yi
et al., 2011) and not through b-catenin activation of target genes.
Additional work has also found that inhibition of Wnt promotes
the conversion of naive mESCs to ‘‘primed’’ EpiSCs (ten Berge
et al., 2011). Importantly, hESCs are considered to be in a primed
pluripotent state, similar to mouse EpiSCs (Tesar et al., 2007).
Our data showing that inhibition of Wnt signaling by Dkk1
promotes hESC pluripotency are therefore in agreement with
these recent findings.
A prediction of our model is that crosstalk signaling between
the Erk and Wnt pathways also controls mesoderm induction
during early vertebrate development. Although the Raf/Mek/ErkF-IRES-GFP vector in +HAI, ±Dkk1 for 3 days.
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Figure 7. Model of Signaling Networks that Regulate Self-Renewal and Differentiation of Human Pluripotent Stem Cells
(A) Model summarizing the self-renewing state, when PI3K/Akt signaling is active. Akt first modulates the threshold of Smad2,3 activity and second inhibits Erk
and maintains Gsk3b activity, compatible with Nanog expression.
(B) Model summarizing the differentiated state. Upon PI3K/Akt inactivation, Activin A/Smad2,3 signaling is enhanced and Erk is activated, and when coupled
with Wnt signaling, promotes Gsk3b inhibition and b-catenin activation. Subsequently, Smad2/3 and Wnt effectors cooperate to promote the activation of
mesendoderm markers, such as MixL1. Nanog expression is lost after 4 days of differentiation.
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mesoderm induction in vertebrate embryogenesis through tran-
scriptional regulators such as Eomesodermin, Xbra, and Mix1
(Heasman, 2006), the relationship among these pathways has
not been clearly established. Although PI3K/Akt is unlikely to be
involved in this scenario, our studies in human pluripotent cells
in vitro have allowed us to uncover what we propose to be
a mechanism that broadly applies to mesendoderm induction
in vivo. As an extension of ourmodel, we propose that Erk activa-
tion crosstalks with Gsk3b to activate canonical Wnt signaling
duringmesodermandendoderm induction. Furthermore, studies
in Xenopus have shown that the ability of Activin to induce
mesoderm in animal cap assays is dependent upon Erk activity
(LaBonne and Whitman, 1994). Although the molecular mecha-
nism for this is unclear, we predict that Erk, in conjunction with
Wnt, promotes b-catenin activation such that it may cooperate
with Smad2,3 complexes to activate mesodermal gene expres-
sion during embryonic development.
In summary, we have defined a framework to explain how cell
signaling pathways coordinate the balance between self-
renewal and differentiation. Central to this framework is the
activity of PI3K/Akt that allows Activin A/Smad2,3 signaling
to promote self-renewal. In the absence of PI3K signaling,
Smad2,3 collaborates with Wnt pathway effectors to promote
differentiation. This model has far-reaching implications not
only for cell fate commitment in pluripotent cells in vitro but
also for cell fate determination in early embryonic development.
EXPERIMENTAL PROCEDURES
Cell Culture
hESCs (WA01, WA07,WA09, fromWiCell, Madison,WI, and BG01, BG02 from
Novocell, Athens, GA) and hiPSCs (Fib2-iPS4, from Dr. George Daley) were
routinely maintained in HAI (basis for StemPro hESC SFM, Invitrogen) or
AIF100 media, by a variation to the method previously described (Wang
et al., 2007).324 Cell Stem Cell 10, 312–326, March 2, 2012 ª2012 Elsevier Inc.Immunoblotting, Immunostaining, and qRT-PCR
Immunostaining and immunoblotting was performed as previously described
(Smith et al., 2010; Bechard and Dalton, 2009). qRT-PCR was performed
with Taqman assays (Applied Biosystems) on a iCycler (Bio-Rad), according
tomanufacturer instructions. qRT-PCR assays performed in triplicate, normal-
ized to Gapdh, and analyzed according to the DDCT method. Data are repre-
sentative of multiple experiments.
Immunoprecipitation and Chromatin Immunoprecipitation
Immunoprecipitation assays were performed by lysis in mammalian cell
lysis buffer (Bechard and Dalton, 2009) and detected with an anti-rabbit light
chain-specific HRP-conjugated secondary antibody (Millipore). Chromatin
immunoprecipitation assays were performed as previously described
(Smith et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/j.
stem.2012.01.014.
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